申请人:Warner-Lambert Company
公开号:US06528510B1
公开(公告)日:2003-03-04
The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.
本发明涉及具有改进药理特性的新型带有连环杂环的二氢吡喃,能有效抑制HIV天冬氨酸蛋白酶,阻断HIV的感染性。这些二氢吡喃在开发治疗病毒感染和疾病,包括艾滋病的疗法方面是有用的。本发明还涉及合成这些二氢吡喃的方法,以及在制备最终化合物中有用的中间体。